BLRX

BioLineRX
BLRX

Overview Fund Trends Analyst Outlook Journalist POV

29 hedge funds and large institutions have $6.69M invested in BioLineRX in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

97% less call options, than puts

Call options by funds: $13K | Put options by funds: $408K

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13K
Puts
$408K
Net Calls
Net Calls Change

Top Buyers

1
+$2.95M
2
+$328K
3
+$212K
4
PAM
PVG Asset Management
Colorado
+$210K
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$118K

Top Sellers

1
-$888K
2
-$168K
3
-$47K
4
Millennium Management
Millennium Management
New York
-$42K
5
IP
Intellectus Partners
California
-$32.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$2K
28
$1K
29
$36
30
–
31
–
32
–
33
–
34
–
1
2